Current
3.4×
5-Year Average
4.6×
All-Time High
6.9×
All-Time Low
1.0×
P/B Ratio daily chart for Thermo Fisher Scientific (TMO)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/B Ratio for Thermo Fisher Scientific (TMO) from 2001 to 2025
| 2025 | $217.87B | $53.41B | 4.1× | +0.1× | |
| 2024 | $199.17B | $49.58B | 4.0× | -0.4× | |
| 2023 | $205.42B | $46.73B | 4.4× | -0.5× | |
| 2022 | $215.32B | $43.98B | 4.9× | -1.5× | |
| 2021 | $262.89B | $40.79B | 6.4× | +1.1× | |
| 2020 | $184.91B | $34.51B | 5.4× | +1.0× | |
| 2019 | $129.62B | $29.68B | 4.4× | +1.1× | |
| 2018 | $89.96B | $27.59B | 3.3× | +0.3× | |
| 2017 | $76.14B | $25.41B | 3.0× | +0.4× | |
| 2016 | $55.68B | $21.54B | 2.6× | -0.1× | |
| 2015 | $56.67B | $21.35B | 2.7× | +0.2× | |
| 2014 | $49.84B | $20.55B | 2.4× | +0.0× | |
| 2013 | $40.29B | $16.86B | 2.4× | +0.9× | |
| 2012 | $22.84B | $15.46B | 1.5× | +0.4× | |
| 2011 | $16.79B | $15.04B | 1.1× | -0.3× | |
| 2010 | $21.51B | $15.36B | 1.4× | +0.1× | |
| 2009 | $19.53B | $15.43B | 1.3× | +0.3× | |
| 2008 | $14.23B | $14.93B | 1.0× | -0.7× | |
| 2007 | $24.08B | $14.49B | 1.7× | +0.3× | |
| 2006 | $19.03B | $13.91B | 1.4× | -0.4× | |
| 2005 | $4.91B | $2.79B | 1.8× | -0.1× | |
| 2004 | $4.86B | $2.67B | 1.8× | +0.1× | |
| 2003 | $4.16B | $2.38B | 1.7× | +0.1× | |
| 2002 | $3.28B | $2.03B | 1.6× | -0.6× | |
| 2001 | $4.16B | $1.91B | 2.2× | — |
- 20254.1×
- 20244.0×
- 20234.4×
- 20224.9×
- 20216.4×
- 20205.4×
- 20194.4×
- 20183.3×
- 20173.0×
- 20162.6×
- 20152.7×
- 20142.4×
- 20132.4×
- 20121.5×
- 20111.1×
- 20101.4×
- 20091.3×
- 20081.0×
- 20071.7×
- 20061.4×
- 20051.8×
- 20041.8×
- 20031.7×
- 20021.6×
- 20012.2×
About P/B Ratio at Thermo Fisher Scientific (TMO)
Thermo Fisher Scientific (TMO) P/B ratio is 3.4× as of June 5, 2026. The 5-year average is 4.6×. The sector median currently stands at 3.4×. The current ratio is at the 8th percentile of its own 10-year history.
Thermo Fisher Scientific (TMO) historical P/B ratio has ranged from a low of 1.0× (2008) to a high of 6.9× (2021) in the available daily series.
The price-to-book (P/B) ratio compares a company's market capitalisation to its book value of equity (total shareholders' equity) on the most recent quarterly balance sheet. It is calculated as market cap ÷ book value of equity (equivalent to share price ÷ book value per share). A P/B below 1× implies the market values the business below its accounting net worth; values well above 1× reflect intangible assets, brand value, or a high return on equity.
Thermo Fisher Scientific P/B Ratio by Year
Thermo Fisher Scientific P/B Ratio 2025: 4.1×
Thermo Fisher Scientific (TMO) P/B ratio in 2025 was 4.1×, expanded from 4.0× the prior year.
Thermo Fisher Scientific P/B Ratio 2024: 4.0×
Thermo Fisher Scientific (TMO) P/B ratio in 2024 was 4.0×, contracted from 4.4× the prior year.
Thermo Fisher Scientific P/B Ratio 2023: 4.4×
Thermo Fisher Scientific (TMO) P/B ratio in 2023 was 4.4×, contracted from 4.9× the prior year.
Thermo Fisher Scientific P/B Ratio 2022: 4.9×
Thermo Fisher Scientific (TMO) P/B ratio in 2022 was 4.9×, contracted from 6.4× the prior year.
Thermo Fisher Scientific P/B Ratio 2021: 6.4×
Thermo Fisher Scientific (TMO) P/B ratio in 2021 was 6.4×.
Sector peers by P/B Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/B Ratio — table
Healthcare peers of Thermo Fisher Scientific (TMO), ranked by P/B ratio.
| 2.9× | |
| 2.7× | |
| 2.6× | |
| 2.6× | |
| 2.5× | |
| 2.5× | |
| 2.4× | |
| 2.4× | |
| 2.3× | |
| 1.8× | |
| 1.8× | |
| 1.7× | |
| 1.7× | |
| 1.6× | |
| 1.5× | |
| 1.5× | |
| 1.5× | |
| 1.4× | |
| 1.4× | |
| 1.4× | |
| 1.2× | |
| 1.2× | |
| 1.1× | |
| 1.1× | |
| 0.8× |
- 2.7×
- 2.4×
- 2.3×
- 1.8×
- 1.7×
- 1.4×
- 1.4×
- 1.2×
- 1.1×
- 1.1×
- 0.8×
Frequently asked questions
Thermo Fisher Scientific (TMO) Key Financials
Charts, filings, and peer comparison for every metric